留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

重症新型冠状病毒肺炎:是急性呼吸窘迫综合征吗?

李旭 马晓春

李旭, 马晓春. 重症新型冠状病毒肺炎:是急性呼吸窘迫综合征吗?[J]. 协和医学杂志, 2021, 12(2): 184-188. doi: 10.3969/j.issn.1674-9081.2021.01.005
引用本文: 李旭, 马晓春. 重症新型冠状病毒肺炎:是急性呼吸窘迫综合征吗?[J]. 协和医学杂志, 2021, 12(2): 184-188. doi: 10.3969/j.issn.1674-9081.2021.01.005
LI Xu, MA Xiao-chun. Severe Coronavirus Disease 2019: Is It Acute Respiratory Distress Syndrome?[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(2): 184-188. doi: 10.3969/j.issn.1674-9081.2021.01.005
Citation: LI Xu, MA Xiao-chun. Severe Coronavirus Disease 2019: Is It Acute Respiratory Distress Syndrome?[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(2): 184-188. doi: 10.3969/j.issn.1674-9081.2021.01.005

重症新型冠状病毒肺炎:是急性呼吸窘迫综合征吗?

doi: 10.3969/j.issn.1674-9081.2021.01.005
详细信息
    通讯作者:

    马晓春  电话:024-83282631,E-mail:xcma2972@sina.com

  • 中图分类号: R18; R441.9

Severe Coronavirus Disease 2019: Is It Acute Respiratory Distress Syndrome?

More Information
    Corresponding author: MA Xiao-chun  Tel: 86-24-83282631, E-mail: xcma2972@sina.com
  • 摘要: 新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)在全球暴发流行,危害严重。虽然目前临床研究和尸检结果提高了人们对COVID-19的认识,但仍存在诸多争议,最大的争议之一即为重症COVID-19是否可诊断为急性呼吸窘迫综合征(acute respiratory distress syndrome,ARDS)。重症COVID-19符合ARDS柏林标准,但与其他原因导致的ARDS存在诸多不同之处,包括发病晚、部分患者肺顺应性相对正常、高碳酸血症出现较早、肺CT表现和肺凝血活化明显。目前对COVID-19相关ARDS的分型多基于观察性研究,偏倚较大。至今其病理生理过程尚未明确,过早分型可能误导机械通气策略,期待大样本临床研究结果带来更多证据。
    作者贡献:李旭负责撰写文章初稿;马晓春负责选题设计和文章审校。
    利益冲突:  无
  • [1] World Health Organization. Coronavirus disease (COVID-19) Weekly Epidemiological Update[EB/OL]. (2020-08-10). https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200907-weekly-epi-update-4.pdf?sfvrsn=f5f607ee_2.
    [2] Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians[J]. Am J Respir Crit Care Med, 2020. doi:  10.1164/rccm.202006-2157CP.
    [3] Couzin-Frankel J. The mystery of the pandemic's 'happy hypoxia'[J]. Science, 2020, 368: 455-456. doi:  10.1126/science.368.6490.455
    [4] Li X, Ma XC. Acute respiratory failure in COVID-19: is it "typical" ARDS?[J]. Crit Care, 2020, 24: 198. doi:  10.1186/s13054-020-02911-9
    [5] Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA, et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19[J]. J Thromb Haemost, 2020, 18: 1517-1519. doi:  10.1111/jth.14844
    [6] Gattinoni L, Coppola S, Cressoni M, et al. Covid-19 does not lead to a "typical" acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2020, 201: 1299-1300. doi:  10.1164/rccm.202003-0817LE
    [7] Grasselli G, Zangrillo A, Zanella A, et al. COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy[J]. JAMA, 2020, 323: 1574-1581. doi:  10.1001/jama.2020.5394
    [8] Wan Y, Shang J, Graham R, et al. Receptor recognition by the novel Coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS Coronavirus[J]. J Virol, 2020, 94: e00127-20. http://www.researchgate.net/publication/338948394_Receptor_recognition_by_novel_coronavirus_from_Wuhan_An_analysis_based_on_decade-long_structural_studies_of_SARS
    [9] Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19[J]. Lancet, 2020, 395: 1417-1418. doi:  10.1016/S0140-6736(20)30937-5
    [10] ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition[J]. JAMA, 2012, 307: 2526-2533. http://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/140729/Home
    [11] Gattinoni L, Marini JJ, Pesenti A, et al. The "baby lung" became an adult[J]. Intensive Care Med, 2016, 42: 663-673. doi:  10.1007/s00134-015-4200-8
    [12] Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome[J]. N Engl J Med, 2017, 377: 1904-1905.
    [13] 刘大为. 急性呼吸窘迫综合征: 前世与今生[J]. 协和医学杂志, 2020, 11: 501-507. doi:  10.3969/j.issn.1674-9081.2020.05.001
    [14] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395: 497-506. doi:  10.1016/S0140-6736(20)30183-5
    [15] Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study[J]. Lancet Respir Med, 2020, 8: 475-481. doi:  10.1016/S2213-2600(20)30079-5
    [16] Wichmann D, Sperhake JP, Lütgehetmann M, et al. Auto-psy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study[J]. Ann Intern Med, 2020, 6: M20-2003. http://www.researchgate.net/publication/341204334_Autopsy_Findings_and_Venous_Thromboembolism_in_Patients_With_COVID-19_A_Prospective_Cohort_Study
    [17] Lang M, Som A, Mendoza DP, et al. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT[J]. Lancet Infect Dis, 2020, 30: S1473-3099(20)30367-4. http://www.sciencedirect.com/science/article/pii/S1473309920303674
    [18] Mahjoub Y, Rodenstein DO, Jounieaux V. Severe Covid-19 disease: rather AVDS than ARDS?[J]. Crit Care, 2020, 24: 327. doi:  10.1186/s13054-020-02972-w
    [19] Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not[J]. Crit Care, 2020, 24: 154. doi:  10.1186/s13054-020-02880-z
    [20] Zhao ZQ, Kung WH, Chang HT, et al. COVID-19 pneumonia: phenotype assessment requires bedside tools[J]. Crit Care, 2020, 24: 272. doi:  10.1186/s13054-020-02973-9
    [21] Robba C, Battaglini D, Ball L, et al. Distinct phenotypes require distinct respiratory management strategies in severe COVID-19[J]. Respir Physiol Neurobiol, 2020, 279: 103455. doi:  10.1016/j.resp.2020.103455
    [22] Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19[J]. N Engl J Med, 2020, 383: 120-128. doi:  10.1056/NEJMoa2015432
    [23] Mangalmurti NS, Reilly JP, Cines DB, et al. COVID-ARDS Clarified: A Vascular Endotype?[J]. Am J Respir Crit Care Med, 2020. doi:  10.1164/rccm.202006-2598LE.
  • 加载中
计量
  • 文章访问数:  463
  • HTML全文浏览量:  116
  • PDF下载量:  52
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-08-13
  • 录用日期:  2020-09-17
  • 网络出版日期:  2020-12-01
  • 刊出日期:  2021-05-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!